216 related articles for article (PubMed ID: 33612458)
1. Effect of varying quantities of polymer on preparation and stability evaluation of carbamazepine cocrystals with dicarboxylic acid coformers.
Wasim M; Mannan A; Ullah K; Yameen MA; Latif M; Ahmad T; Ullah M; Amirzada MI; Khan HU; Maheen S; Khan SA; Jamil QA; Bin Asad MHH; Hussain I
Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1755-1761. PubMed ID: 33612458
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of Carbamazepine Cocrystals: Characterization,
Wasim M; Mannan A; Asad MHHB; Amirzada MI; Shafique M; Hussain I
Biomed Res Int; 2021; 2021():6685806. PubMed ID: 33816628
[TBL] [Abstract][Full Text] [Related]
3. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
[TBL] [Abstract][Full Text] [Related]
4. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
Yamashita H; Sun CC
Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
Rahman Z; Samy R; Sayeed VA; Khan MA
Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
[TBL] [Abstract][Full Text] [Related]
6. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
Qiu S; Li M
Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
[TBL] [Abstract][Full Text] [Related]
7. Dissolution Profiles of Carbamazepine Cocrystals with Cis-Trans Isomeric Coformers.
Omori M; Yamamoto H; Matsui F; Sugano K
Pharm Res; 2023 Feb; 40(2):579-591. PubMed ID: 35194718
[TBL] [Abstract][Full Text] [Related]
8. Formation mechanism of a new carbamazepine/malonic acid cocrystal polymorph.
Limwikrant W; Nagai A; Hagiwara Y; Higashi K; Yamamoto K; Moribe K
Int J Pharm; 2012 Jul; 431(1-2):237-40. PubMed ID: 22537807
[TBL] [Abstract][Full Text] [Related]
9. Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide.
Rahman Z; Agarabi C; Zidan AS; Khan SR; Khan MA
AAPS PharmSciTech; 2011 Jun; 12(2):693-704. PubMed ID: 21598082
[TBL] [Abstract][Full Text] [Related]
10. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.
Liu X; Lu M; Guo Z; Huang L; Feng X; Wu C
Pharm Res; 2012 Mar; 29(3):806-17. PubMed ID: 22009589
[TBL] [Abstract][Full Text] [Related]
11. Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution.
Sathisaran I; Dalvi SV
AAPS PharmSciTech; 2021 Jan; 22(1):29. PubMed ID: 33404968
[TBL] [Abstract][Full Text] [Related]
12. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach.
Yamashita H; Sun CC
Pharm Res; 2020 Jul; 37(8):153. PubMed ID: 32705421
[TBL] [Abstract][Full Text] [Related]
13. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
14. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
15. Understanding impact of pre-dissolved polymers on dissolution behavior of soluble carbamazepine cocrystal.
Ullah M; Khan SA; Shah SM; Rabbani I; Sadozai SK; Abbas N; Bin Asad MHH; Badshah M; Hasan SMF; Hussain I
Pak J Pharm Sci; 2019 May; 32(3):1049-1055. PubMed ID: 31278719
[TBL] [Abstract][Full Text] [Related]
16. New cocrystals of heterocyclic drugs: structural, antileishmanial, larvicidal and urease inhibition studies.
Murtaza G; Khan M; Farooq S; Choudhary MI; Yousuf S
Acta Crystallogr C Struct Chem; 2023 Jun; 79(Pt 6):237-248. PubMed ID: 37140892
[TBL] [Abstract][Full Text] [Related]
17. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
Boksa K; Otte A; Pinal R
J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
[TBL] [Abstract][Full Text] [Related]
18. Melt Crystallization of Celecoxib-Carbamazepine Cocrystals with the Synchronized Release of Drugs.
Chen A; Cai P; Luo M; Guo M; Cai T
Pharm Res; 2023 Feb; 40(2):567-577. PubMed ID: 36348133
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.
Ullah M; Ullah H; Murtaza G; Mahmood Q; Hussain I
Biomed Res Int; 2015; 2015():870656. PubMed ID: 26380301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
